Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

NCT06932081 · clinicaltrials.gov ↗

RECRUITING

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Adult Congenital Heart Disease
Congenital Heart Disease
Systemic Right Ventricle
Transposition of the Great Arteries
Congenitally Corrected Transposition of the Great Arteries
Fontan
Single Ventricle
Tetralogy of Fallot (TOF)

Interventions

DRUG: SGLT2 inhibitors

Sponsor

Leiden University Medical Center